Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 15.82% is 17% below its 5-year average of 19.17%, around the middle of its 5-year range (4.31%–23.15%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.44% below its 12-month average of 18.93%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 15.82%.
DEBT TO ASSETS RATIO
15.82%
DEBT TO ASSETS RATIO AVG TTM
18.93%
DEBT TO ASSETS RATIO AVG 3Y
19.21%
DEBT TO ASSETS RATIO AVG 5Y
19.17%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-16.44%
CURRENT VS 3Y AVG
-17.66%
CURRENT VS 5Y AVG
-17.49%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 846 covered companies
CURRENT VS SECTOR MEDIAN
+17477.87%
vs the sector median at left
C4 Therapeutics, Inc.
Market Cap
$313.46M
Debt to Assets Ratio
15.82%
TTM Avg
18.93%
3Y Avg
19.21%
5Y Avg
19.17%
Market Cap
$320.22M
Debt to Assets Ratio
1.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$321.22M
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$321.76M
Debt to Assets Ratio
0.70%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$321.79M
Debt to Assets Ratio
0.74%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$303.72M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$302.73M
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | $313.46M | 15.82% | 18.93% | 19.21% | 19.17% |
| Agenus Inc. (AGEN)vs › | $320.18M | 0.24% | N/A | N/A | N/A |
| Avita Medical Inc. (RCEL)vs › | $320.22M | 1.01% | N/A | N/A | N/A |
| Cabaletta Bio, Inc. (CABA)vs › | $321.22M | 0.10% | N/A | N/A | N/A |
| Sanara MedTech Inc. (SMTI)vs › | $321.76M | 0.70% | N/A | N/A | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $321.79M | 0.74% | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $303.72M | 0.00% | N/A | N/A | N/A |
| CapsoVision, Inc. (CV)vs › | $323.36M | 0.04% | N/A | N/A | N/A |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $302.73M | 0.04% | N/A | N/A | N/A |
| Larimar Therapeutics, Inc. (LRMR)vs › | $291.39M | 0.03% | N/A | N/A | N/A |
Debt/Assets
15.8%
Debt/Equity
0.23
Current Ratio
5.45
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 15.82% |
| 2026-03-31 | 17.77% |
| 2025-12-31 | 16.70% |
| 2025-09-30 | 23.15% |
| 2025-06-30 | 21.22% |
| 2025-03-31 | 20.14% |
| 2024-12-31 | 18.81% |
| 2024-09-30 | 17.84% |
| 2024-06-30 | 17.95% |
| 2024-03-31 | 17.50% |
| 2023-12-31 | 18.85% |
| 2023-09-30 | 21.68% |
| 2023-06-30 | 22.32% |
| 2023-03-31 | 21.58% |
| 2022-12-31 | 20.23% |
| 2022-09-30 | 19.08% |
| 2022-06-30 | 17.53% |
| 2022-03-31 | 16.96% |
| 2021-12-31 | 8.46% |
| 2021-09-30 | 4.47% |
| 2021-06-30 | 4.31% |
| 2021-03-31 | 6.11% |
| 2020-12-31 | 5.73% |
| 2020-09-30 | 10.03% |
| 2020-06-30 | 9.27% |
| 2019-12-31 | 11.63% |
